These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10401724)

  • 21. [Nephrotoxicity of tacrolimus and preventive effect of diltiazem: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Lu YM; Liang JJ; Zhang J; Qiu J; Xie KJ; Hu JB; Zhong WD; Wang B; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):704-8. PubMed ID: 19595068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of tacrolimus in Thai kidney transplant patients: comparison with similar data from other populations.
    Vadcharavivad S; Praisuwan S; Techawathanawanna N; Treyaprasert W; Avihingsanon Y
    J Clin Pharm Ther; 2016 Jun; 41(3):310-28. PubMed ID: 27191538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients.
    Sam WJ; Tham LS; Holmes MJ; Aw M; Quak SH; Lee KH; Lim SG; Prabhakaran K; Chan SY; Ho PC
    Clin Pharmacokinet; 2006; 45(1):59-75. PubMed ID: 16430311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients.
    Choong CL; Wong HS; Lee FY; Lee CK; Kho JV; Lai YX; Vikneswaran T
    Transplant Proc; 2018 Oct; 50(8):2515-2520. PubMed ID: 30316389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hesperidin on the oral pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
    Cho YA; Choi DH; Choi JS
    J Pharm Pharmacol; 2009 Jun; 61(6):825-9. PubMed ID: 19505375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
    Katari SR; Magnone M; Shapiro R; Jordan M; Scantlebury V; Vivas C; Gritsch A; McCauley J; Starzl T; Demetris AJ; Randhawa PS
    Clin Transplant; 1997 Jun; 11(3):237-42. PubMed ID: 9193849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the protective effect of dietary fish oil on uranyl-nitrate-induced nephrotoxicity and oxidative damage in rat kidney.
    Priyamvada S; Khan SA; Khan MW; Khan S; Farooq N; Khan F; Yusufi AN
    Prostaglandins Leukot Essent Fatty Acids; 2010 Jan; 82(1):35-44. PubMed ID: 19931439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of traditional chinese medicine Wuzhi capsule on pharmacokinetics of tacrolimus in rats.
    Wei H; Tao X; Di P; Yang Y; Li J; Qian X; Feng J; Chen W
    Drug Metab Dispos; 2013 Jul; 41(7):1398-403. PubMed ID: 23628674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplementation with omega-3 polyunsaturated fatty acids and experimental tacrolimus-induced nephrotoxicity.
    Fernandes MB; Caldas HC; Toloni LD; Baptista MA; Fernandes IM; Abbud-Filho M
    Exp Clin Transplant; 2014 Dec; 12(6):522-7. PubMed ID: 25489802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 1,25-dihydroxyvitamin D3 and diltiazem on tissue calcium in uremic rat.
    Inagaki O; Nakagawa K; Syono T; Nishian Y; Takenaka Y; Takamitsu Y
    Ren Fail; 1995 Nov; 17(6):651-7. PubMed ID: 8771237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus pharmacokinetics in BMT patients.
    Boswell GW; Bekersky I; Fay J; Wingard J; Antin J; Weisdorf D; Maher R; Fitzsimmons W; Nash R
    Bone Marrow Transplant; 1998 Jan; 21(1):23-8. PubMed ID: 9486490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrolimus-induced nephrotoxicity and genetic variability: a review.
    Gijsen VM; Madadi P; Dube MP; Hesselink DA; Koren G; de Wildt SN
    Ann Transplant; 2012; 17(2):111-21. PubMed ID: 22743729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of fibrosis in experimental tacrolimus nephrotoxicity.
    Shihab FS; Bennett WM; Tanner AM; Andoh TF
    Transplantation; 1997 Dec; 64(12):1829-37. PubMed ID: 9422427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of epigallocatechin gallate on the bioavailability and pharmacokinetics of diltiazem in rats.
    Li C; Choi JS
    Pharmazie; 2008 Nov; 63(11):815-8. PubMed ID: 19069242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diltiazem use in tacrolimus-treated renal transplant recipients.
    Kothari J; Nash M; Zaltzman J; Ramesh Prasad GV
    J Clin Pharm Ther; 2004 Oct; 29(5):425-30. PubMed ID: 15482385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of tacrolimus after the first oral administration in renal transplant recipients on triple immunosuppressive therapy.
    Velickovic-Radovanovic RM; Paunovic G; Mikov M; Djordjevic V; Stojanovic M; Catic-Djordjevic A; Cvetkovic T
    Basic Clin Pharmacol Toxicol; 2010 Jun; 106(6):505-10. PubMed ID: 20102364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.
    Bhaloo S; Prasad GV
    Transplant Proc; 2003 Nov; 35(7):2449-51. PubMed ID: 14611983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction.
    Okabe H; Hashimoto Y; Inui KI
    J Pharm Pharmacol; 2000 Dec; 52(12):1467-72. PubMed ID: 11197074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin mRNA expression and renal dysfunction in tacrolimus-induced acute nephrotoxicity.
    Nakatani T; Uchida J; Iwai T; Matsumura K; Naganuma T; Kuratsukuri K; Sugimura K
    Int J Mol Med; 2003 Jan; 11(1):75-8. PubMed ID: 12469222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.